Help Us Protect Access to Sexual and Reproductive Health Care Today!
Apr 18
Updated March 27, 2024 Nearly four years ago, we celebrated the 20th anniversary of mifepristone and looked back on the history of this medication and how it expanded the options available for those seeking abortion care. French researchers developed mifepristone (also known as RU-486) in the 1980s to be taken with misoprostol for medication abortion…
Aug 30
RHAP is excited to re-introduce Insights, a revival of our short, monthly e-newsletter offering primary care clinicians evidence-based education on abortion and early pregnancy loss care. Modeled after Contraceptive Pearls, Insights will share practice guidelines, clinical tools, and resources that reinforce and support evidence-based, person-centered abortion and early pregnancy loss care and counseling, including post-abortion and self-managed…
Aug 16
Since the Supreme Court’s decision in Dobbs v. Jackson Health Women’s Organization to overturn Roe v. Wade and Planned Parenthood v. Casey, states where abortion access is secure (aka “surge states”) have experienced an unprecedented rise in patients who have the privilege and resources to travel out of state to seek care. This increased demand has put enormous strain on existing…
Aug 09
RHAP lent its perspective and expertise to the research that resulted in two recently published studies that address access to medication abortion in family medicine. “Family Physicians’ Barriers and Facilitators in Incorporating Medication Abortion” highlights the role training and technical assistance play in supporting family physicians to provide medication abortion. “Exploring the impact of mifepristone’s…
Jul 01
It has been one week since the Supreme Court’s decision in Dobbs v. Jackson Health Women’s Organization overturned Roe v. Wade and Planned Parenthood v. Casey, removing all federal protections for abortion access. In this past week, we have already seen states moving quickly to severely restrict or outright ban abortion care; as of today,…
Jun 28
The Reproductive Health Care and Advocacy Fellowship is excited to announce that we are now accepting applications for fellows to start in the summer of 2023! This one-year fellowship aims to train a diverse community of family medicine leaders to provide, teach, and advocate for access to equitable and person-centered reproductive health care, including abortion,…
Jun 21
“The AAFP is a powerful organization. Advocacy at NCCL gave me the opportunity to help direct AAFP policy and funds to causes that concern my patients and practice.” – Monica Agarwal, MD, New Jersey RHAP Fellow, and New Physician Delegate to NCCL In April over 200 family physicians reunited in Kansas City for the first…
Jun 16
Taking mifepristone with misoprostol is a safe, effective, and common way to have a medication abortion. This combination has been available in the United States since 2000. Mifepristone with misoprostol can be used up to 11 weeks of pregnancy, when the vast majority of abortions in this country occur, and can also be easily offered in…
Jun 07
As we learned last month, the Supreme Court is poised to fully overturn Roe v. Wade in a few any day now. While the pending ruling in the Dobbs v. Jackson Women’s Health Organization case is likely to make abortion illegal in at least 26 states, we know that even with Roe as the law of the land, abortion access…
Jun 06
Self-sourced medication abortion or self-managed abortion (SMA) is “safe, effective, and empowering.” It offers an important alternative to clinical care, especially now that the U.S. Supreme Court is poised to decimate the legal right to abortion. SMA is a reproductive justice and human rights issue; providing people with the tools and information to manage their…